CANCER EPIGENOMICS: A REVIEW
Journal Title: Internet Journal of Medical Update - Year 2011, Vol 6, Issue 1
Abstract
Epigenetic inactivation of genes that are crucial for the control of normal cell growth is a hallmark of cancer cells. Epigenetic modifications of the DNA do not alter the nucleotide sequence instead they involve the regulation of gene transcription and DNA methylation. Hypermethylation or histone deacetylation, which is within the promoter of a tumor suppressor gene, leads to the silencing as well as a deletion or a mutation of that gene. Cancer cells often show aberrant methylation and the frequency of aberrations increases is seen with the progression of disease. Hypermethylation events can occur early in tumorogenesis, involving the disruption of pathways that may predispose cells to malignant transformation. Epigenetic modification such as DNA methylation can be exploited for clinical purposes in cancer patients, first using hypermethylation as a molecular biomarker of cancer cells and second, epigenetic changes which are potentially reversible.
Authors and Affiliations
Robby kumar, Nishant Sharan
Keywords
Related Articles
- EP ID EP144878
- DOI -
- Views 101
- Downloads 0
‘Radiopath’- an assimilation of radiology and pathology: a need of the day
Diabesity: Curse of Development
DIABETIC MUSCLE INFARCTION - A CASE REPORT
Diabetic muscle infarction is a rare complication in patients of long standing diabetes mellitus with multiple end organ microvascular sequelae. A case of a 69 year old lady with a 10 year history of diabetes mellitus, w...
Charles-Edouard Brown-Séquard: The Biography of a Tormented Genius by Louis-Cyril Celestin
THE NEW FACE OF ULTRASOUND IMAGING: A GIFT BY NANOTECHNOLOGY
The search for novel ultrasound contrast agents has now led to the use of nanoparticles due to their ability to generate contrast, amalgamation of numerous properties, adequate circulation times and satisfactory safety i...